U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893548) titled 'Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation ... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895771) titled 'Minimal Sedation Versus Standard Continuous Sedation After Out-of-Hospital Cardiac Arrest' ... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07896304) titled 'Intravenous Dexamethasone to Prolong Caudal Block Analgesia in Children Undergoing Hip Surg... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895719) titled 'Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial' on O... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894432) titled 'Correlation Between Trunk Muscle Endurance and Dynamic Balance in Sacroiliac Joint Dysfunct... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893379) titled 'joyVision: The Superiority of Co-design in the Development of a Serious Game for Children W... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895004) titled 'Comparing an AI-driven Hearing Test With the Standard Hearing Test in Adults With Hearing L... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial To Evaluate The Efficacy And Safe... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A two-part, First-In-Human, phase I, open-label, ascending dose study to assess safety and tolerab... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... Read More